FDA warns of Edwards Lifesciences heart valve delivery system issue after death and injury

On October 15, 2026, the U.S. FDA issued a high-risk warning regarding certain Edwards Lifesciences Commander M delivery systems used with the SAPIEN M3 transcatheter mitral valve replacement system. Edwards requested customers stop using and return the devices following three reports of balloons bursting during inflation. As of October 5, 2026, one death and one serious injury have been linked to the issue. Balloon bursts can obstruct blood vessels or impede device retrieval, requiring surgery.

Edwards Lifesciences delivery system recall

• ▪Edwards Lifesciences requested that customers discontinue use of certain Commander M delivery systems and return affected products to the manufacturer.
• ▪Edwards Lifesciences initiated the delivery system recall after receiving three reports of device balloons bursting during inflation.

Balloon burst mechanism

• ▪The reported Edwards Lifesciences delivery system failure occurs when device balloons burst during the inflation phase of transcatheter mitral valve replacement.
• ▪The U.S. Food and Drug Administration reported that delivery system balloon bursts can prevent retrieval of the Edwards Lifesciences device from a patient's body.

FDA safety warning

• ▪The U.S. Food and Drug Administration flagged the safety issue for certain Commander M delivery systems used in transcatheter mitral valve replacement procedures.
• ▪On October 15, 2026, the U.S. Food and Drug Administration issued a safety warning regarding a high-risk issue with certain Edwards Lifesciences heart valve delivery systems.

SAPIEN M3 valve system

• ▪The affected Commander M delivery systems are used with Edwards Lifesciences' SAPIEN M3 transcatheter mitral valve replacement system.
• ▪The Edwards Lifesciences SAPIEN M3 transcatheter mitral valve replacement system received U.S. Food and Drug Administration approval in December 2025.

Blood vessel obstruction risks

• ▪Edwards Lifesciences delivery system balloon bursts could necessitate additional surgical procedures in patients generally considered unsuitable for surgery.
• ▪The U.S. Food and Drug Administration warned that Edwards Lifesciences delivery system balloon bursts could block blood vessels in patients.